Blood test may reveal hidden heart risks

NCT ID NCT07276256

Completed Knowledge-focused Sponsor: Kırıkkale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 552 people hospitalized with acute coronary syndrome, a serious heart condition. Researchers calculated a value called the leukoglycemic index (LGI) from routine blood tests and compared it to the SYNTAX score, which measures how complex the coronary artery disease is. The goal was to see if LGI could help predict disease severity. The study is complete and observational, meaning it does not test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors use a simple blood test to quickly assess how severe a patient's heart disease might be.
What could go wrong: This is an observational study, not a treatment trial. It only looks for a link between two measurements and cannot prove cause or improve outcomes directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROMES (ACS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute coronary syndrome coronary artery disorder Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CORONARY SYNDROMES (ACS)

Contacts and locations

Locations

Kırıkkale university

Kirikkale, Kırıkkale, 71000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.